Quick Summary
Forsythia suspensa is a traditional Chinese medicinal herb primarily investigated as part of Chinese patent medicine formulations targeting respiratory infections and inflammatory diseases. It contains bioactive compounds such as forsythiaside, rutin, quercetin, and kaempferol. Extracts of Forsythia suspensa have been studied for their anti-inflammatory and antiviral properties, including activity against respiratory syncytial virus (RSV). However, clinical evidence specific to Forsythia as a single herb is limited, with most data derived from multi-herbal formulations. Preclinical animal studies support its anti-inflammatory effects. Overall, current clinical evidence on the efficacy and safety of Forsythia suspensa remains preliminary and mostly integrated within combined traditional preparations.
What is it?
Forsythia suspensa is a flowering plant used in Traditional Chinese Medicine (TCM). The dried fruit of the plant is commonly utilized in herbal formulations. It has a long history of use in TCM, often combined with other herbs in patent medicines for treating respiratory and inflammatory conditions.
Traditional Uses
Traditionally, Forsythia suspensa has been employed to support respiratory health, particularly for symptoms associated with infections and inflammation. It has been included in formulations aimed at reducing fever, clearing heat, alleviating sore throat, and managing inflammatory diseases.
Active Compounds
- Forsythiaside
- Rutin
- Quercetin
- Kaempferol
- Hyperoside (noted for potential effects on metabolic and liver conditions)
Potential Benefits with Evidence Levels
- Anti-respiratory infection effect: Forsythia suspensa extract demonstrates anti-inflammatory and antiviral activities against respiratory syncytial virus in animal models by modulating immune responses and Toll-like receptor signaling pathways. (Preclinical – animal studies)
- Adjunctive therapy for respiratory diseases: Used within Chinese patent medicines for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and viral pneumonia, Forsythia-containing formulations may help symptom relief and reduce inflammation markers, although with low to very low certainty evidence. (Low to very low certainty human clinical evidence in multi-herb formulations)
- Anti-inflammatory potential: A meta-analysis of animal studies indicates Forsythia suspensa extracts reduce inflammatory cytokines and oxidative stress markers relevant to inflammatory diseases. (Preclinical – animal meta-analysis)
- Supports management of viral pneumonia and COVID-19 symptoms: Forsythia is widely used in TCM combinations to potentially reduce symptoms and inflammation in viral pneumonia and COVID-19. Evidence generally supports multi-herb TCM use but specific high-quality trials on Forsythia alone are limited. (Low to moderate certainty human evidence within combination therapies)
- Potential benefit in metabolic and liver diseases: Compounds such as hyperoside in Forsythia suspensa may modulate fatty acid and bile acid metabolism, relevant in non-alcoholic fatty liver disease models in animals. (Preclinical – animal studies)
Side Effects
Forsythia suspensa is generally well tolerated based on traditional use and preclinical data. Mild gastrointestinal symptoms have been reported, though specific adverse effects of Forsythia alone are not clearly documented in human studies. Adverse effects observed in multi-herb formulations containing Forsythia are generally mild and comparable to control groups.
Drug Interactions
There is no specific evidence regarding drug interactions involving Forsythia suspensa. Due to a lack of systematic evaluation, caution is advised when combining Forsythia with conventional medications.
Who Should Avoid It
No specific contraindications for Forsythia suspensa have been reported. However, pregnant and breastfeeding individuals should exercise caution as safety data during these periods are lacking.
Evidence Limitations
Most clinical evidence concerns multi-herb Chinese patent medicines containing Forsythia suspensa rather than Forsythia alone, limiting the ability to attribute observed effects solely to Forsythia. The overall quality of evidence is generally low to very low due to methodological limitations and absence of large, well-controlled randomized trials. While preclinical evidence supports anti-inflammatory and antiviral mechanisms, clinical validation is necessary. Safety and drug interaction data specific to Forsythia remain scarce.
References
- Integrated Metabolomics and Network Pharmacology to Reveal the Mechanisms of Forsythia suspensa Extract Against Respiratory Syncytial Virus. (2025)
- Efficacy of Forsythia suspensa (Thunb.) Vahl on mouse and rat models of inflammation-related diseases: a meta-analysis. (2024)
- Non-alcoholic fatty liver disease alleviation by hyperoside from Forsythia suspensa through modulation of fatty acid and bile acid metabolism. (2025)
- Traditional Chinese Medicine and Herbal Medicine in the Management of Viral Respiratory Diseases: A Review. (2025)
- Combination of Chinese herbal medicine and conventional western medicine for coronavirus disease 2019: a systematic review and meta-analysis. (2023)
- Efficacy and safety of traditional Chinese medicine injections for older adults with community-acquired pneumonia: An evidence map. (2025)
Last Reviewed
June 2024
Disclaimer: This page is for informational purposes only and does not constitute medical advice. Forsythia suspensa has been studied mainly as part of multi-herb traditional formulations. Consult a qualified healthcare professional before using this herb, especially if you are pregnant, breastfeeding, have underlying health conditions, or are taking medications.